PERSEUS SOROS BIOPHARMACEUTICAL FUND LP

CIK 00011114086 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001111408

Recent Transactions

24 trades

Other
MAP Pharmaceuticals, Inc.
Common Stock
2010-05-11−1,000,000→ 1,826,169 total
Other
MAP Pharmaceuticals, Inc.
Common Stock
2010-02-11−1,250,000→ 2,826,169 total
Other
BIOENVISION INC
Common Stock
2007-07-10$5.60/sh−3,375,044→ 0 total
Other
BIOENVISION INC
Series A Convertible Preferred Stock
2007-07-10$3.00/sh−2,250,000→ 0 total
Sale
Adams Respiratory Therapeutics, Inc.
Common Stock, par value $0.01 per share
2005-12-14$43.75/sh−1,715,458→ 3,372,918 total
Conversion
Adams Respiratory Therapeutics, Inc.
Common Stock, par value $0.01 per share
2005-07-26+3,619,690→ 5,177,604 total
Conversion
Adams Respiratory Therapeutics, Inc.
Series B Convertible Preferred Stock
2005-07-26−3,619,690→ 0 total
Sale
Adams Respiratory Therapeutics, Inc.
Common Stock
2005-07-26$15.81/sh−1,609,000→ 5,088,376 total
Conversion
Adams Respiratory Therapeutics, Inc.
Common Stock
2005-07-26+1,519,772→ 6,697,376 total
Conversion
Adams Respiratory Therapeutics, Inc.
Series C Convertible Preferred Stock
2005-07-26−1,519,772→ 0 total
Purchase
AUXILIUM PHARMACEUTICALS INC
Warrants to Purchase Common Stock
2005-06-30+153,022→ 153,022 total
Purchase
AUXILIUM PHARMACEUTICALS INC
Common Stock
2005-06-30$4.90/sh+612,089→ 3,877,403 total
Sale
BARRIER THERAPEUTICS INC
Common Stock, par value $.0001 per share ("Common Stock")
2005-02-15$19.50/sh−430,004→ 2,324,734 total
Other
BIOENVISION INC
Common Stock
2004-12-13−1,500,000→ 375,044 total
Conversion
BIOENVISION INC
Common Stock, $0.001 par value ("Common Stock")
2004-12-13+1,500,000→ 1,875,044 total
Other
BIOENVISION INC
Common Stock
2004-12-13−1,500,000→ 375,044 total
Conversion
BIOENVISION INC
Series A Convertible Participating Preferred Stock
2004-12-13−750,000→ 2,250,000 total
Conversion
BIOENVISION INC
Series A Convertible Participating Preferred Stock
2004-12-13−750,000→ 2,250,000 total
Conversion
BIOENVISION INC
Common Stock, $0.0001 par value ("Common Stock")
2004-12-13+1,500,000→ 1,875,044 total
Conversion
BARRIER THERAPEUTICS INC
Series B Convertible Preferred Stock
2004-04-28−4,666,667→ 0 total
Conversion
BARRIER THERAPEUTICS INC
Common Stock, $.0001 par value
2004-04-28+2,754,738→ 2,754,738 total
Conversion
BARRIER THERAPEUTICS INC
Series C Convertible Preferred Stock
2004-04-28−842,810→ 0 total
Purchase
Vaneltix Pharma, Inc.
Common Stock, $.001 par value
2003-12-31$2.05/sh+487,805→ 1,892,334 total
Purchase
Vaneltix Pharma, Inc.
Common Stock Purchase Warrant (right to buy)
2003-12-31+195,122→ 195,122 total

Companies

Recent Filings

Address

888 SEVENTH AVE 30TH FLR

NEW YORK, NY, 10106

View on SEC.gov